Publications by authors named "Renee Perdok"

Claim this Profile
C
Cytisinicline for smoking cessation in individuals with self-reported COPD: a post hoc analysis of the ORCA-2 and ORCA-3 trials.
Judith Prochaska, Mark Rubinstein, Renee Perdok, Brent Blumenstein, Cindy Jacobs

Thorax· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Teprotumumab for the Treatment of Active Thyroid Eye Disease.
Raymond S Douglas, George J Kahaly, Amy Patel, Saba Sile, Elizabeth H Z Thompson, Renee Perdok

N Engl J Med· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, double-blind, placebo-controlled study of interferon- 1b in Friedreich Ataxia.
David R Lynch, Lauren Hauser, Ashley McCormick, McKenzie Wells, Yi Na Dong, Renee Perdok

Ann Clin Transl Neurol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of glycerol phenylbutyrate in pediatric patients 2 months to 2 years of age with urea cycle disorders.
Susan A Berry, Jerry Vockley, Alexander A Vinks, Min Dong, George A Diaz, Renee Perdok

Mol Genet Metab· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of ABT-874, a monoclonal anti-interleukin 12/23 antibody, for the treatment of chronic plaque psoriasis: 36-week observation/retreatment and 60-week open-label extension phases of a randomized phase II trial.
Alexa B Kimball, Kenneth B Gordon, Richard G Langley, Alan Menter, Renee J Perdok

J Am Acad Dermatol· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for radiographic progression in psoriatic arthritis: subanalysis of the randomized controlled trial ADEPT.
Dafna D Gladman, Philip J Mease, Ernest H S Choy, Christopher T Ritchlin, Renee J Perdok

Arthritis Res Ther· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of adalimumab in treatment of patients with psoriatic arthritis who had failed disease modifying antirheumatic drug therapy.
Mark C Genovese, Philip J Mease, Glen T D Thomson, Alan J Kivitz, Renee J Perdok

J Rheumatol· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adalimumab for long-term treatment of psoriatic arthritis: forty-eight week data from the adalimumab effectiveness in psoriatic arthritis trial.
Dafna D Gladman, Philip J Mease, Christopher T Ritchlin, Ernest H S Choy, John T Sharp, Renee J Perdok

Arthritis Rheum· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trial.
Philip J Mease, Dafna D Gladman, Christopher T Ritchlin, Eric M Ruderman, Serge D Steinfeld, Renee J Perdok

Arthritis Rheum· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis